Skip to main content
Midas Edge

MESA LABORATORIES INC CO

For the period ended Jun 30, 2024. Filed Aug 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 5, 2024

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity

(dollars in thousands, except per share data)

Common Stock
Number of SharesAmount(Accumulated Deficit) Retained EarningsAOCI*Total
March 31, 20245,394,491$343,642$(183,494)$(14,755)$145,393
Exercise of stock options and vesting of restricted stock units20,858----
Tax withholding on vesting of restricted stock units(6,194)(571)--(571)
Dividends paid, $0.16 per share--(863)-(863)
Stock-based compensation expense-2,928--2,928
Foreign currency translation---452452
Net income--3,388-3,388
June 30, 20245,409,155$345,999$(180,969)$(14,303)$150,727
Common Stock
Number of SharesAmount(Accumulated Deficit) Retained EarningsAOCI*Total
March 31, 20235,369,466$332,076$74,199$(12,795)$393,480
Exercise of stock options and vesting of restricted stock units20,07452--52
Tax withholding on vesting of restricted stock units(5,260)(712)--(712)
Dividends paid, $0.16 per share--(859)-(859)
Stock-based compensation expense-2,968--2,968
Foreign currency translation---(6,661)(6,661)
Net (loss)--(549)-(549)
June 30, 20235,384,280$334,384$72,791$(19,456)$387,719

*Accumulated Other Comprehensive Income (Loss).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.